MINNEAPOLIS -- The second trial in the Levaquin antibiotic multidistrict litigation ended in a defense verdict June 17 when a jury in the U.S. District Court for the District of Minnesota found that defendant Ortho-McNeil-Janssen Pharmaceuticals Inc.... Read More